Ads
related to: influenza c antibodies treatment cost
Search results
Results From The WOW.Com Content Network
Viferon is a suppository of (non-pegylated [12]) interferon alpha-2b, ascorbic acid (vitamin C), and tocopherol (vitamin E) which was reported in two small studies to be as effective as arbidol. [13] [14] Another interferon alfa-2b medicine, "Grippferon", nasal drops, is used for treatment and emergency prevention of Influenza and cold. [15]
Influenza viruses are members of the family Orthomyxoviridae. [2] Influenza viruses A, B, C, and D represent the four antigenic types of influenza viruses. [3] Of the four antigenic types, influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is usually only associated with minor symptoms.
Polyvalent influenza vaccine is a type of influenza vaccine that provides immunity against more than one type of antigen. [1] In the second week after receiving the flu shot, the body's immune system is triggered by the antigens so the body starts producing antibodies. These antibodies help fight against influenza viruses.
The U.S. Department of Health and Human Services (HHS) has exercised its option to purchase an additional 10,000 doses of BioCryst Pharmaceuticals Inc's (NASDAQ: BCRX) antiviral influenza therapy ...
Vaccine manufacturers are on track to deliver 194 to 198 million doses for the 2020-2021 flu season, about 30 million more than last year, according to the Centers for Disease Control and ...
The influenza vaccine is indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. [ 74 ] [ 75 ] [ 76 ] The US Centers for Disease Control and Prevention (CDC) recommends the flu vaccine as the best way to protect people against the flu and prevent its ...
Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray that is recommended for the prevention of influenza. [ 2 ] [ 7 ] It is an attenuated live vaccine, unlike other influenza vaccines, which are inactivated vaccines .
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) [2] and patented in September 2006. [3] The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency ...